Vivo Capital »

Alpine Immune Sciences shares owned by Vivo Capital

Quarter-by-quarter ownership of Alpine Immune Sciences shares owned by Vivo Capital from 13F filings

Historical chart of Vivo Capital investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Vivo Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Vivo Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $21M 521k 39.95
2023-12-31 $16M 819k 19.06
2023-09-30 $11M 915k 11.45
2023-06-30 $9.4M 915k 10.28

More positions owned by Vivo Capital

Soleno Therapeutics Common (SLNO)
Geron Corp Common (GERN)
Harmony Biosciences Holdings Common (HRMY)
Sinovac Biotech SHS (SVA)
Avadel Pharmaceuticals Adr
Verona Pharma Sponsored Ads (VRNA)
ALX Oncology Holdings Common (ALXO)
Dyne Therapeutics Common (DYN)
Terns Pharmaceuticals Common (TERN)
Astria Therapeutics Common (ATXS)
Viridian Therapeutics Common (VRDN)
Silence Therapeutics Ads (SLN)
Olema Pharmaceuticals Common (OLMA)
Adverum Biotechnologies Common (ADVM)
Alpine Immune Sciences Common

View all positions for Vivo Capital